MedTrace Logo

Frailty Study of Older Adults Getting Chemotherapy and Radiation Therapy

NCT01808833 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 4

Last updated 2014-01-29

No results posted yet for this study

Summary

The investigators hypothesize that frailty assessment prior to concurrent chemotherapy and radiation therapy in the elderly will predict treatment-related toxicity and morbidity and that such assessment at serial time points will help improve treatment and outcomes for these patients.

Conditions

Sponsors & Collaborators

  • The University of Texas Health Science Center at San Antonio

    lead OTHER

Principal Investigators

  • Anand Karnad, MD · University of Texas

Eligibility

Min Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2013-11-30
Completion
2013-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01808833 on ClinicalTrials.gov